Rick Turner









J. Rick Turner, Ph.D.



Dr Rick Turner is an experimental research scientist who spent the first 15 years of his career in academic cardiovascular behavioral medicine research, investigating the putative role of behavioral stress in the etiology of hypertension.  He worked at three university medical schools, and published 50 papers in peer-reviewed journals in this research field.  He then moved into the pharmaceutical industry as a medical writer, running his own company, Turner Medical Communications LLC, and working for GlaxoSmithKline.

In 2005 he moved to the Campbell University School of Pharmacy (Research Triangle Park, NC) where he is Associate Professor of Clinical Research and the School’s Drug Safety Scholar.  His main areas of interest are the design and analysis of clinical trials, and the cardiac safety of noncardiac drugs.  He has recently published three books in these areas, and given several talks on cardiac safety at national meetings.  He is also a member of the Cardiac Safety Research Consortium.

Dr Turner is also very interested in communicating the scientific and clinical aspects of drug development and pharmacotherapy to the general public, and helping health journalists to report on these issues accurately and informatively.  He has been invited to participate in a workshop on “The Pitfalls of Reporting Clinical Trials” at the 6th World Conference of Science Journalists in London, June 2009, and looks forward to participating in more such ventures.




Featured

Healthcare summit as interesting as Olympic curling
February 25, 2010  
Maine’s drug-disposal bill should be thrown out
February 19, 2010  
Ambiguity is Power
February 17, 2010  

Stay Informed

Receive latest news & event updates
Provide email below:


Bookmark and Share